期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 28, 期 11, 页码 567-572出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2007.10.006
关键词
-
In 2005, the first evidence was obtained that the cannabinoid CB, receptor contains an allosteric binding site. The site can be recognized by synthetic small molecules, which display a markedly divergent effect on orthosteric ligand affinity versus efficacy; these small molecules are allosteric enhancers of agonist binding affinity and allosteric inhibitors of agonist signalling efficacy. Allosteric modulation heralds a new approach to the manipulation of the endocannabinoid system for therapeutic benefit; it promises to augment the existing portfolio of selective direct agonists, competitive antagonists and enzyme inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据